Valeant Pharma reports quarterly loss, to interchange title to Bausch Health

Valeant Pharmaceuticals reported first-quarter loss when put next with a year-previously profit and mentioned on Tuesday it might perhaps well well substitute its title to Bausch Health Firms.

Win loss attributable to the company turn into as soon as at $2.sixty nine billion, or $7.sixty eight per part, in the quarter ended March 31, when put next with a profit of $628 million, or $1.Seventy nine per part, a year earlier.

Complete revenues fell 5.four % to $1.ninety six billion.